SULJE VALIKKO

avaa valikko

Hiroshi Maeda (ed.) | Akateeminen Kirjakauppa

Haullasi löytyi yhteensä 3 tuotetta
Haluatko tarkentaa hakukriteerejä?



Polymer Drugs in the Clinical Stage : Advantages and Prospects
Tekijä: Hiroshi Maeda (ed.); Alexander Kabanov (ed.); Kazunori Kataoka (ed.); Teruo Okano (ed.)
Kustantaja: Springer (2003)
Saatavuus: Noin 17-20 arkipäivää
EUR   129,90
Neocarzinostatin : The Past, Present, and Future of Anticancer Drug
Tekijä: Hiroshi Maeda (ed.); Kiyoto Edo (ed.); Nakao Ishida (ed.)
Kustantaja: Springer (2013)
Saatavuus: Noin 17-20 arkipäivää
EUR   97,90
The Role of Nitric Oxide in Physiology and Pathophysiology
Tekijä: Hilary Koprowski (ed.); Hiroshi Maeda (ed.)
Kustantaja: Springer (2011)
Saatavuus: Noin 17-20 arkipäivää
EUR   49,60
    
Polymer Drugs in the Clinical Stage : Advantages and Prospects
129,90 €
Springer
Sivumäärä: 226 sivua
Asu: Kovakantinen kirja
Painos: 2003
Julkaisuvuosi: 2003, 31.03.2003 (lisätietoa)
Kieli: Englanti

Proceedings of the International Symposium on Polymer Therapeutics - Recent Progress in Clinics and Future Prospects, held July 13-14, 2001, in Nara, Japan.


The technology of polymer science has developed considerably during the past half-century, and this volume describes some of the aspects of this technology that will have a great impact in the future. Among these advances, for example, are gene delivery to specific disease sites and carrier polymers that respond to a stimulus or particular environment. Cancer targeted drug delivery is another focused area of this volume because of the important nature of EPR-effect of polymer drugs in tumor. Included are discussions of as many examples as possible of polymer drugs that have achieved, or are close to clinical use. The concept of "Polymer drugs" here is limited to primarily injectable and water-soluble agents, although also covered are some drugs in micellar form or liposomes.


This book is intended for students and researchers in the field of pharmacology who have particular interests in drug delivery, targeting, and formulation, as well as for clinicians such as oncologists who are interested in the field. People who work at regulatory agencies should also be aware such that drugs with great potential are being developed and will be beneficial to many patients, as well as to health insurance agencies because of improved cost effectiveness.



Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
LISÄÄ OSTOSKORIIN
Tilaustuote | Arvioimme, että tuote lähetetään meiltä noin 17-20 arkipäivässä
Myymäläsaatavuus
Helsinki
Tapiola
Turku
Tampere
Polymer Drugs in the Clinical Stage : Advantages and Prospectszoom
Näytä kaikki tuotetiedot
Sisäänkirjautuminen
Kirjaudu sisään
Rekisteröityminen
Oma tili
Omat tiedot
Omat tilaukset
Omat laskut
Lisätietoja
Asiakaspalvelu
Tietoa verkkokaupasta
Toimitusehdot
Tietosuojaseloste